NXTC Archived Articles
NextCure (NXTC): A Clinical-Stage Biopharma Advancing Innovative Cancer Treatments
Published on March 15, 2025
NextCure, Inc. (NASDAQ:NXTC): Prioritizing Highest-Value Opportunities in Cancer Immunotherapy
Published on November 28, 2024
NextCure, Inc. (NXTC): Advancing Innovative Therapies with a Focused Pipeline
Published on September 24, 2024